Rearming the body’s immune system to fight cancer
We’re developing more precise and more accessible treatment alternatives for patients with solid cancers
Pioneering excellence in the field of immunotherapy
Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.
Some of our partners
Latest news
Clinical Trials Bite Off Chunk of CAR T Therapy Market
By Christine Filippis / August 6, 2019
https://www.the-scientist.com/news-opinion/clinical-trials-bite-off-chunk-of-car-t-therapy-market-66212 About a quarter of lymphoma patients eligible for the cancer treatments are opting for experimental—and free—options instead. Jul 30,...
Read More
CAR-T Cell Cancer Therapy to Save Lives (Media Release)
By Christine Filippis / August 5, 2019
https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/ The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients CAR-T Cell Therapy is...
Read More
Australian Actor Tom Long cancer-free after medical trial
By Christine Filippis / July 29, 2019
The Age, 28 July 2019 By Melissa Cunningham Former SeaChange actor Tom Long was on the brink of death when...
Read More
